Semnur Pharmaceuticals, Inc.
€ 8,00
€ 0,00
(0,00%)
Marktkapitalisatie: 1,84 B
Prijs
€ 8,00
Marktkapitalisatie
1,84 B
Dagbereik
€ 8,00 — € 8,00
52-Weeksbereik
€ 8,00 — € 23,00
Volume
50
Openen € 8,00
50D / 200D Gem.
€ 8,03
0,40% below
50D / 200D Gem.
€ 10,47
23,60% below
Koershistorie
Financiële Trends
No fundamental snapshot available yet.
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2022 | FY2023 |
|---|---|---|---|---|
| Revenue | — | 50,00 M | — | — |
| Net Income | -160,42 M | -167.306,0 | -419.390,0 | 632.536,0 |
| EPS (Diluted) | -0,78 | — | — | — |
| Gross Profit | — | — | — | — |
| Operating Income | -160,42 M | -1,65 M | — | — |
| EBITDA | — | — | — | — |
| R&D Expenses | 2,55 M | — | — | — |
| SG&A Expenses | — | — | — | — |
| D&A | — | — | — | — |
| Interest Expense | — | 96.242,0 | — | 36.909,0 |
| Income Tax | 0,0 | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2022 | FY2023 |
|---|---|---|---|---|
| Total Assets | 1,35 M | 9,04 M | 86,28 M | 50,69 M |
| Total Liabilities | 22,10 M | 10,43 M | 4,18 M | 8,49 M |
| Shareholders' Equity | -20,75 M | -10,42 M | -3,27 M | -8,28 M |
| Total Debt | — | — | — | — |
| Cash & Equivalents | 20.000,0 | — | — | 204.464,0 |
| Current Assets | 596.000,0 | 16.868,0 | 907.836,0 | 209.440,0 |
| Current Liabilities | 10,17 M | 7,55 M | 1,29 M | 5,60 M |
{"event":"ticker_viewed","properties":{"ticker":"SMNR","listing_kind":"stock","pathname":"/stocks/smnr","exchange":"OTC","country":"US"}}